留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

糖尿病性心肌病患者外周血单个核细胞NLPR3和NF-κB表达及与心肌灌注的相关性

孟莎莎 李楠 刘晓华

孟莎莎, 李楠, 刘晓华. 糖尿病性心肌病患者外周血单个核细胞NLPR3和NF-κB表达及与心肌灌注的相关性[J]. 中华全科医学, 2025, 23(10): 1681-1684. doi: 10.16766/j.cnki.issn.1674-4152.004204
引用本文: 孟莎莎, 李楠, 刘晓华. 糖尿病性心肌病患者外周血单个核细胞NLPR3和NF-κB表达及与心肌灌注的相关性[J]. 中华全科医学, 2025, 23(10): 1681-1684. doi: 10.16766/j.cnki.issn.1674-4152.004204
MENG Shasha, LI Nan, LIU Xiaohua. The expression of NLPR3 and NF-κB in peripheral blood mononuclear cells of patients with diabetic cardiomyopathy and their correlation with myocardial perfusion[J]. Chinese Journal of General Practice, 2025, 23(10): 1681-1684. doi: 10.16766/j.cnki.issn.1674-4152.004204
Citation: MENG Shasha, LI Nan, LIU Xiaohua. The expression of NLPR3 and NF-κB in peripheral blood mononuclear cells of patients with diabetic cardiomyopathy and their correlation with myocardial perfusion[J]. Chinese Journal of General Practice, 2025, 23(10): 1681-1684. doi: 10.16766/j.cnki.issn.1674-4152.004204

糖尿病性心肌病患者外周血单个核细胞NLPR3和NF-κB表达及与心肌灌注的相关性

doi: 10.16766/j.cnki.issn.1674-4152.004204
基金项目: 

山东省医药卫生科技发展计划项目 202203010192

详细信息
    通讯作者:

    刘晓华,E-mail:405065168@qq.com

  • 中图分类号: R587.2 R542.2

The expression of NLPR3 and NF-κB in peripheral blood mononuclear cells of patients with diabetic cardiomyopathy and their correlation with myocardial perfusion

  • 摘要:   目的  探讨糖尿病性心肌病(DCM)患者外周血单个核细胞核苷酸结合寡聚化结构域样受体蛋白3(NLPR3)、核转录因子KappaB(NF-κB)表达特点及其与患者心肌灌注发展的相关性。  方法  选取2023年6月—2024年6月康复大学青岛医院的100例糖尿病患者分为DCM组(36例)和糖尿病组(64例),30例健康体检者为对照组。采用ROC曲线评估NLPR3、NF-κB诊断DCM的效能;采用Pearson相关性分析研究NLPR3、NF-κB与心肌灌注总运动负荷(SSS)、总静息(SRS)评分的相关性。  结果  DCM组NLPR3、NF-κB表达(1.67±0.28、2.21±0.65)高于糖尿病组(1.04±0.20、1.57±0.38),糖尿病组均高于对照组(0.76±0.10、0.75±0.10, F=172.319、91.669,P<0.05);NLPR3、NF-κB、联合检测诊断DCM的曲线下面积为0.963、0.847、0.990(P<0.05);DCM组SSS、SRS评分[(19.68±8.19)分、(13.10±4.62)分]均高于糖尿病组[(6.36±1.04)分、(5.21±1.92)分],左心室射血分数[(34.14±15.58)%]低于糖尿病组[(53.21±8.58)%,t=12.877、11.980、7.907,P<0.05];DCM患者NLPR3、NF-κB表达与SSS、SRS评分呈正相关关系(r=0.449、0.367、0.353、0.401,均P<0.05)。  结论  DCM患者外周血单个核细胞NLPR3、NF-κB表达升高,可协助临床诊断DCM,可能参与心肌灌注发展过程。

     

  • 图  1  外周血单个核细胞NLPR3、NF-κB表达诊断糖尿病患者合并DCM的ROC曲线

    Figure  1.  ROC curve analysis of NLRP3 and NF-κB expression in peripheral blood mononuclear cells for diagnosing DCM in diabetic patients

    表  1  2组糖尿病患者和健康对照组临床资料比较

    Table  1.   Comparison of clinical data between two groups of diabetic patients and the healthy control group

    组别 例数 性别[例(%)] 年龄(x ±s,岁) BMI (x ±s) 收缩压(x ±s,mmHg) 舒张压(x ±s,mmHg)
    男性 女性
    DCM组 36 20(55.56) 16(44.44) 56.84±5.61 20.38±1.32 125.80±10.49 78.34±7.38
    糖尿病组 64 33(51.56) 31(48.44) 56.03±5.85 20.10±1.25 122.91±10.50 76.74±8.40
    对照组 30 16(53.33) 14(46.67) 55.24±5.38 19.95±1.45 123.38±11.36 77.34±7.69
    统计量 0.149a 0.653b 0.939b 0.873b 0.464b
    P 0.928 0.522 0.394 0.420 0.630
    注:a为χ2值,bF值;1 mmHg=0.133 kPa。
    下载: 导出CSV

    表  2  2组糖尿病患者和健康对照组外周血单个核细胞NLPR3、NF-κB表达比较(x ±s)

    Table  2.   Comparison of NLPR3 and NF-κB expressions in peripheral blood mononuclear cells between the diabetic group and the healthy control group(x ±s)

    组别 例数 NLPR3 NF-κB
    DCM组 36 1.67±0.28ab 2.21±0.65ab
    糖尿病组 64 1.04±0.20b 1.57±0.38b
    对照组 30 0.76±0.10 0.75±0.10
    F 172.319 91.669
    P <0.001 <0.001
    注:与糖尿病组比较,aP < 0.05;与对照组比较,bP < 0.05。
    下载: 导出CSV

    表  3  外周血单个核细胞NLPR3、NF-κB表达对DCM的预测价值分析

    Table  3.   Predictive value of NLRP3 and NF-κB expression in peripheral blood mononuclear cells for DCM

    指标 最佳截断值 约登指数 灵敏度(%) 特异度(%) SE AUC 95% CI P
    NLPR3 1.25 0.835 94.00 89.00 0.021 0.963 0.904~0.990 <0.001
    NF-κB 1.81 0.583 83.00 75.00 0.043 0.847 0.761~0.911 <0.001
    联合检测 0.913 94.00 96.00 0.007 0.990 0.945~1.000 <0.001
    下载: 导出CSV

    表  4  2组糖尿病患者心肌灌注指标比较(x ±s)

    Table  4.   Comparison of myocardial perfusion indicators between two groups of diabetic patients(x ±s)

    组别 例数 SSS(分) SRS(分) LVEF(%)
    DCM组 36 19.68±8.19 13.10±4.62 34.14±15.58
    糖尿病组 64 6.36±1.04 5.21±1.92 53.21±8.58
    t 12.877 11.980 7.907
    P <0.001 <0.001 <0.001
    下载: 导出CSV

    表  5  DCM患者外周血单个核细胞NLPR3、NF-κB表达与心肌灌注指标的相关性

    Table  5.   Correlation between NLRP3 and NF-κB expression in peripheral blood mononuclear cells and myocardial perfusion indicators in patients with DCM

    项目 NLPR3 NF-κB
    SSS r 0.449 0.353
    P <0.001 0.010
    SRS r 0.367 0.401
    P 0.003 <0.001
    下载: 导出CSV
  • [1] 于向慧, 和欢, 张茹, 等. 凝集素样氧化低密度脂蛋白受体1基因敲除对糖尿病性心肌病保护作用的研究[J]. 中国糖尿病杂志, 2022, 30(12): 925-933.

    YU X H, HE H, ZHANG R, et al. Study on the protective effect of lectin-like oxidized low-density lipoprotein receptor 1 gene knockout in diabetic cardiomyopathy[J]. Chin J Diabetes, 2022, 30(12): 925-933.
    [2] 王毅, 尤红俊, 韩稳琦, 等. 糖尿病性心肌病小鼠心肌线粒体circRNA表达谱与功能富集分析[J]. 西安交通大学学报: 医学版, 2023, 44(5): 701-708.

    WANG Y, YOU H J, HAN W Q, et al. Analysis of circRNA expression profile and functional enrichment of myocardial mitochondria in mice with diabetic cardiomyopathy[J]. J Xi'an Jiaotong Univ (Med Sci), 2023, 44(5): 701-708.
    [3] 张花治, 金智生, 孙金宁, 等. 红芪多糖对db/db小鼠糖尿病心肌病NF-κB/IKKβ信号通路的影响[J]. 中国临床药理学杂志, 2024, 40(6): 849-853.

    ZHANG H Z, JIN Z S, SUN J N, et al. Effects of Hedysarum polybotrys polysacchcaide on NF-κB/IKKβ signaling pathway in db/db mice with diabetic cardiomyopathy[J]. Chin J Clin Pharmacol, 2024, 40(6): 849-853.
    [4] 刘晨阳, 杨海晨, 耿嘉逸, 等. NLRP3和白细胞介素6受体与房颤相关性研究[J]. 蚌埠医学院学报, 2024, 49(1): 23-27.

    LIU C Y, YANG H C, GENG J Y, et al. Correlation between NLRP3, IL-6R and atrial fibrillation[J]. J Bengbu Med Coll, 2024, 49(1): 23-27.
    [5] 刘一潼, 周穗子, 邱前辉. NLRP3炎症小体在慢性鼻窦炎和变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 142-146, 153.

    LIU Y T, ZHOU S Z(review), QIU Q H(checking). Research progress on NLRP3 inflammasome in chronic rhinosinusitis and allergic rhinitis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2022, 36(3): 142-146, 153.
    [6] HAO J J, ZHOU J D, HU S Q, et al. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation[J]. Am J Physiol Cell Physiol, 2024, 326(2): C331-C347. doi: 10.1152/ajpcell.00467.2023
    [7] SUN Q, GUO W X, YUE T, et al. NLRP3 inflammasome mechanism and therapeutic targets in diabetic cardiomyopathy[J]. Gac Med Mex, 2023, 159(3): 255-261.
    [8] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344.

    Diabetes society of Chinese medical association. Chinese guidelines for the prevention and treatment of type 2 diabetes (2017 edition)[J]. Chinese Journal of Practical Internal Medicine, 2018, 38(4): 292-344.
    [9] 朱雅倩, 胡高超, 瞿星光. 血清炎症因子在糖尿病性心肌病患者中的表达及其对心肌细胞线粒体功能的影响[J]. 实用临床医药杂志, 2022, 26(24): 57-60, 85.

    ZHU Y Q, HU G C, QU X G. Expression of serum inflammatory cytokines in patients with diabetic cardiomyopathy and their effects on mitochondrial function of cardiomyocytes[J]. J Clin Med Pract, 2022, 26(24): 57-60, 85.
    [10] 曹丽慧, 孟宪杰, 李会. 外周血miR-4465和miR-6089在亚临床糖尿病性心肌病诊断中的价值[J]. 中南医学科学杂志, 2024, 52(1): 91-93, 105.

    CAO L H, MENG X J, LI H. Analysis of value of peripheral blood miR-4465 and miR-609 detection in the diagnosis of sub-clinical disease progression[J]. Med Sci J Central South Chin, 2024, 52(1): 91-93, 105.
    [11] 崔艺璇, 周翔, 刘宽, 等. 瞬时受体电位通道蛋白5对糖尿病性心肌病炎症的调节作用[J]. 中国药理学通报, 2022, 38(2): 201-208.

    CUI Y X, ZHOU X, LIU K, et al. Regulation of transient receptor potential channel protein 5 in inflammation in diabetic cardiomyopathy[J]. Chin Pharmacol Bull, 2022, 38(2): 201-208.
    [12] 林小淇, 邱晓拂, 袁雪峰, 等. 炎症小体NLRP3调控LPS诱导的前列腺癌增殖和侵袭的机制研究[J]. 解剖学研究, 2022, 44(6): 544-550.

    LIN X Q, QIU X F, YUAN X F, et al. The mechanisms of the regulation of NLRP3 inflammasome on prostate cacner cells proliferation and invasion[J]. Anatomy Res, 2022, 44(6): 544-550.
    [13] 沈子豪, 黄益桃, 游伊珺, 等. 基于PI3K/Akt、NF-κB信号通路探讨中医药防治心肌缺血再灌注损伤的机制[J]. 实用心脑肺血管病杂志, 2023, 31(12): 36-42.

    SHEN Z H, HUANG Y T, YOU Y J, et al. Mechanism of Traditional Chinese Medicine in Preventing and Treating Myocardial Ischemia-Reperfusion Injury Based on the PI3K/Akt, NF-κB Signaling Pathway[J]. Journal of Practical Cardiovascular and Pulmonary Diseases, 2023, 31(12): 36-42.
    [14] 李效丽, 王涛, 董传芳, 等. 水苏碱调节HIF-1α/NLRP3信号通路对缺氧/复氧诱导的心肌细胞焦亡的影响[J]. 中国药学杂志, 2024, 59(24): 2337-2342.

    LI X L, WANG T, DONG C F, et al. Effect of hydrostachyline modulating HIF-1α/NLRP3 signaling pathway on hypoxia/reoxygenation-induced pyroptosis of cardiomyocytes[J]. Chin Pharma J, 2024, 59(24): 2337-2342.
    [15] 王金鑫, 饶春晖, 代波, 等. 绿原酸通过TLR4/NF-κB信号通路调控脓毒症大鼠肠上皮细胞屏障功能的研究[J]. 中华全科医学, 2023, 21(3): 405-408. doi: 10.16766/j.cnki.issn.1674-4152.002894

    WANG J X, RAO C H, DAI B, et al. Chlorogenic acid effects of intestinal epithelial barrier function with septic rats through TLR4/NF-κB signaling pathway[J]. Chinese Journal of General Practice, 2023, 21(3): 405-408. doi: 10.16766/j.cnki.issn.1674-4152.002894
    [16] 姜一凡, 李小荣, 耿嘉逸, 等. 槲皮素通过抑制HMGB1/RAGE/NF-κB信号通路减轻糖尿病引起的大鼠肾脏损伤[J]. 南方医科大学学报, 2024, 44(9): 1769-1775.

    JIANG Y F, LI X R, GENG J Y, et al. Quercetin ameliorates diabetic kidney injury in rats by inhibiting the HMGB1/RAGE/NF-κB signaling pathway[J]. J South Med Univ, 2024, 44(9): 1769-1775.
    [17] ZHANG L X, AI C C, BAI M, et al. NLRP3 inflammasome/pyroptosis: a key driving force in diabetic cardiomyopathy[J]. Int J Mol Sci, 2022, 23(18). DOI: 10.3390/ijms231810632.
    [18] 张赛, 陈正涛, 唐诗韵, 等. NLRP3炎症小体与糖尿病心肌病的关系及中医药调控研究进展[J]. 中国实验方剂学杂志, 2023, 29(16): 250-263.

    ZHANG S, CHEN Z T, TANG S Y, et al. Relationship Between NLRP3 Inflammasome and Diabetic Cardiomyopathy and Intervention Effect of Traditional Chinese Medicine: A Review[J]. Chin J Exp Tradit Med Formulae, 2023, 29(16): 250-263.
    [19] 孙文娟, 孙永红. NF-κB信号通路在儿童川崎病心脏损伤中的研究进展[J]. 中国当代儿科杂志, 2023, 25(3): 250-252.

    SUN W J, SUN Y H. Recent research on the nuclear factor-kappa B signaling pathway in cardiac injury in children with Kawasaki disease[J]. Chin J Contemp Pediatr, 2023, 25(3): 250-252.
    [20] 李利超, 王少博, 程艳, 等. miR-22-3p靶向NLRP3表达对脑缺血再灌注损伤大鼠细胞焦亡的影响[J]. 中国免疫学杂志, 2023, 39(7): 1402-1408.

    LI L C, WANG S B, CHENG Y, et al. Effect of miR-22-3p on pyroptosis of cerebral ischemia-reperfusion injury rats via targeting expression of NLRP3[J]. Chin J Immunol, 2023, 39(7): 1402-1408.
  • 加载中
图(1) / 表(5)
计量
  • 文章访问数:  0
  • HTML全文浏览量:  0
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-03-11

目录

    /

    返回文章
    返回